Agnès Veyradier
Inserm(FR)Université Paris Cité(FR)Sorbonne Université(FR)Sorbonne Paris Cité(FR)Centre de Recherche des Cordeliers(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Saint-Antoine(FR)Laboratoire National de Référence(MA)Hôpital Lariboisière(FR)Centre de Recherche Saint-Antoine(FR)
Publications by Year
Research Areas
Complement system in diseases, Platelet Disorders and Treatments, Renal Diseases and Glomerulopathies, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Blood groups and transfusion
Most-Cited Works
- → Thrombotic thrombocytopenic purpura(2017)672 cited
- → Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies(2016)487 cited
- → Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience(2010)412 cited
- → Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center(2011)287 cited
- → Redefining outcomes in immune TTP: an international working group consensus report(2021)200 cited
- → A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP(2020)180 cited